-
Cochin Shipyard
2,377.00 2,977.10(%) -
Garden Reach Sh.
3,528.00 3,464.85(%) -
Reliance Power
59.93 23.26(%) -
Mazagon Dock
3,460.00 3,778.00(%) -
Brainbees Solut.
410.00 734.25(%) -
Suzlon Energy
68.60 86.04(%) -
Eternal Ltd
260.15 304.50(%) -
Tata Motors
714.00 1,179.05(%) -
Sika Interplant
1,350.35 1,125.30(%) -
Angel One
3,283.00 3,502.60(%) -
Data Pattern
3,208.90 3,654.75(%) -
Reliance Industr
1,454.50 1,608.95(%) -
Bharat Electron
394.60 393.55(%) -
Waaree Energies
2,838.05 1,808.65(%) -
Newgen Software
1,335.70 1,795.50(%) -
Bharat Dynamics
1,981.00 2,096.00(%) -
Railtel Corpn.
464.70 618.00(%) -
Avantel
184.50 212.68(%) -
I R F C
148.00 229.05(%) -
Ircon Intl.
216.70 134.30(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Alembic Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 40294.0
- ISIN : INE901L01018
-
Today’s Low
970.40 -
Today’s High
989.00

-
Open
989.00 -
Perv Close
981.40 -
52W Low
725.20 -
52W High
1,303.90
Key Indicators
-
P/E(TTM)
38.84
-
Mar.Cap (₹Cr.)
19,133.45
-
Div & Yield %
1.13
-
Book Value(₹)
264.28
-
Debt-Equity Ratio
-0.82
-
AGM Date
05-Jun-2025
-
EPS
25.05
-
P/E Ratio
38.84
Financials Ratios
-
Debt-Equity Ratio
0.13
-
Mar.Cap (₹Cr.)
19,133.45
-
RONW (%)
13.40
-
ROCE (%)
12.93
Score Board
-
Equity (₹ in Cr.)
39.31
-
BV (₹)
264.30
-
Sales( ₹ in Cr.)
6,032.63
-
NP (in Cr.)
492.48
-
NP Var(%)
-26.0
-
Div%
550.0
-
CPS (₹)
39.20
-
EPS (₹)
25.10
-
Traded Value (₹ in Lakhs)
19,294.64
-
52 Week High
1,303.90
-
52 Week Low
725.20
-
Price BSE
982.0
-
Price NSE
981.00
-
Market Capital( in Cr.)
19,294.64
-
P/C Ratio
25.10
-
P/E Ratio
39.20
-
Price Vs.BV
25.10
-
02-Jun-2025( 11:58)
Hot Pursuit - Alemb... - <p> According to a regulatory...
-
30-May-2025( 03:42)
Hot Pursuit - Alemb... - Bosutinib tablets are indicate...
-
23-May-2025( 03:08)
Hot Pursuit - Alemb... - Amlodipine and Atorvastatin ta...
-
15-May-2025( 04:36)
Hot Pursuit - Alemb... - The approved ANDA is therapeut...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 5,874.06 | 5,149.00 | 5,035.41 | 5,066.89 | 4,132.55 | 3,660.27 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 5,874.06 | 5,149.00 | 5,035.41 | 5,066.89 | 4,132.55 | 3,660.27 |
Other Income | 31.32 | 3.54 | 51.14 | 83.90 | 134.75 | 6.42 |
Stock Adjustments | 52.36 | -72.84 | -19.85 | 160.65 | 176.50 | 80.42 |
Total Income | 5,957.74 | 5,079.70 | 5,066.70 | 5,311.44 | 4,443.80 | 3,747.11 |
EXPENDITURE : | ||||||
Raw Materials | 1,852.71 | 1,587.29 | 1,482.36 | 1,464.67 | 1,222.39 | 1,080.49 |
Power and Fuel Cost | 173.32 | 151.19 | 120.50 | 118.31 | 97.43 | 88.44 |
Employee Cost | 1,335.91 | 1,094.82 | 1,062.30 | 976.13 | 806.37 | 684.45 |
Other Manufacturing Expenses | 327.87 | 357.21 | 324.10 | 344.44 | 291.44 | 233.95 |
Selling and Administration Expenses | 1,191.90 | 1,173.00 | 1,088.67 | 848.55 | 661.00 | 762.72 |
Miscellaneous Expenses | 46.19 | 48.31 | 28.82 | 26.07 | 37.52 | 11.97 |
Employee Benefit Expenses | 1,335.91 | 1,094.82 | 1,062.30 | 976.13 | 806.37 | 684.45 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 4,927.90 | 4,411.82 | 4,106.75 | 3,778.17 | 3,116.15 | 2,862.02 |
Operating Profit | 1,029.84 | 667.88 | 959.95 | 1,533.27 | 1,327.65 | 885.09 |
Interest | 54.47 | 49.00 | 17.02 | 12.98 | 25.19 | 14.87 |
Gross Profit | 975.37 | 618.88 | 942.93 | 1,520.29 | 1,302.46 | 870.22 |
Depreciation | 271.14 | 272.95 | 284.92 | 182.55 | 135.67 | 105.59 |
Profit Before Tax | 704.23 | 345.93 | 658.01 | 1,337.74 | 1,166.79 | 764.63 |
Current Tax | 37.75 | -0.80 | 114.46 | 241.20 | 197.39 | 153.42 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Reported Net Profit | 666.48 | 346.73 | 543.55 | 1,096.54 | 969.40 | 611.21 |
Extraordinary Items | 0.99 | 0.05 | 2.81 | 5.20 | -7.06 | 2.15 |
Adjusted Net Profit | 665.49 | 346.68 | 540.74 | 1,091.34 | 976.46 | 609.06 |
Adjustment below Net Profit | 0.00 | 0.00 | -76.31 | -114.90 | -51.00 | -43.57 |
P & L Balance brought forward | 3,651.68 | 2,632.89 | 2,440.83 | 1,709.19 | 1,296.49 | 919.76 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 157.25 | -672.07 | 275.19 | 250.00 | 525.97 | 190.91 |
P & L Balance carried down | 4,160.91 | 3,651.69 | 2,632.88 | 2,440.83 | 1,688.92 | 1,296.49 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 550.00 | 400.00 | 500.00 | 700.00 | 500.00 | 275.00 |
Dividend Per Share(Rs) | 11.00 | 8.00 | 10.00 | 14.00 | 10.00 | 5.50 |
Earnings Per Share-Unit Curr | 33.91 | 17.64 | 27.65 | 55.79 | 51.43 | 32.42 |
Earnings Per Share(Adj)-Unit Curr | 33.91 | 17.64 | 27.65 | 55.79 | 51.43 | 32.42 |
Book Value | 249.75 | 224.59 | 269.16 | 259.57 | 177.51 | 143.89 |
Book Value(Adj)-Unit Curr | 249.75 | 224.59 | 269.16 | 259.57 | 177.51 | 143.89 |